ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells

T. C. Yuan, F. F. Lin, S. Veeramani, S. J. Chen, H. S. Earp, Ming-Fong Lin

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Aberrant regulation in the adhesive ability of cancer cells is closely associated with their metastatic activity. In this study, we examine the role of ErbB-2 in regulating the adhesive ability of androgen receptor (AR)-positive human prostate cancer (PCa) cells, the major cell population of PCa. Utilizing different LNCaP and MDA PCa2b cells as model systems, we found that ErbB-2 activity was correlated with PYK2 activity and adhesive ability in those cells. Increased ErbB-2 expression or activity in LNCaP C-33 cells enhanced PYK2 activation and cell adhesion, while the high PYK2 activity and the rapid adhesion of LNCaP C-81 cells were decreased by diminishing ErbB-2 expression or activity. Knockdown studies revealed the predominant role of ErbB-2 in regulating LNCaP C-81 cell adhesion. Coimmunoprecipitation showed that C-81 cells had increased interaction between ErbB-2 and PYK2. Elevated ErbB-2 activity in LNCaP cells correlated with increased ERK/MAPK activity and enhanced adhesive ability, which were abolished by the expression of K457A-PYK2 mutant or the treatment of PD98059, a MEK inhibitor. In summary, our data suggested that ErbB-2, via PYK2-ERK/MAPK, upregulates the adhesive ability of AR-positive human PCa cells.

Original languageEnglish (US)
Pages (from-to)7552-7559
Number of pages8
JournalOncogene
Volume26
Issue number54
DOIs
StatePublished - Nov 29 2007

Fingerprint

Adhesives
Prostatic Neoplasms
Up-Regulation
Cell Adhesion
human AR protein
Mitogen-Activated Protein Kinase Kinases

Keywords

  • Cell adhesion
  • ErbB-2
  • PYK2
  • Prostate cancer

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. / Yuan, T. C.; Lin, F. F.; Veeramani, S.; Chen, S. J.; Earp, H. S.; Lin, Ming-Fong.

In: Oncogene, Vol. 26, No. 54, 29.11.2007, p. 7552-7559.

Research output: Contribution to journalArticle

Yuan, T. C. ; Lin, F. F. ; Veeramani, S. ; Chen, S. J. ; Earp, H. S. ; Lin, Ming-Fong. / ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. In: Oncogene. 2007 ; Vol. 26, No. 54. pp. 7552-7559.
@article{99a6860917d74412be5d603b1089f064,
title = "ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells",
abstract = "Aberrant regulation in the adhesive ability of cancer cells is closely associated with their metastatic activity. In this study, we examine the role of ErbB-2 in regulating the adhesive ability of androgen receptor (AR)-positive human prostate cancer (PCa) cells, the major cell population of PCa. Utilizing different LNCaP and MDA PCa2b cells as model systems, we found that ErbB-2 activity was correlated with PYK2 activity and adhesive ability in those cells. Increased ErbB-2 expression or activity in LNCaP C-33 cells enhanced PYK2 activation and cell adhesion, while the high PYK2 activity and the rapid adhesion of LNCaP C-81 cells were decreased by diminishing ErbB-2 expression or activity. Knockdown studies revealed the predominant role of ErbB-2 in regulating LNCaP C-81 cell adhesion. Coimmunoprecipitation showed that C-81 cells had increased interaction between ErbB-2 and PYK2. Elevated ErbB-2 activity in LNCaP cells correlated with increased ERK/MAPK activity and enhanced adhesive ability, which were abolished by the expression of K457A-PYK2 mutant or the treatment of PD98059, a MEK inhibitor. In summary, our data suggested that ErbB-2, via PYK2-ERK/MAPK, upregulates the adhesive ability of AR-positive human PCa cells.",
keywords = "Cell adhesion, ErbB-2, PYK2, Prostate cancer",
author = "Yuan, {T. C.} and Lin, {F. F.} and S. Veeramani and Chen, {S. J.} and Earp, {H. S.} and Ming-Fong Lin",
year = "2007",
month = "11",
day = "29",
doi = "10.1038/sj.onc.1210570",
language = "English (US)",
volume = "26",
pages = "7552--7559",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "54",

}

TY - JOUR

T1 - ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells

AU - Yuan, T. C.

AU - Lin, F. F.

AU - Veeramani, S.

AU - Chen, S. J.

AU - Earp, H. S.

AU - Lin, Ming-Fong

PY - 2007/11/29

Y1 - 2007/11/29

N2 - Aberrant regulation in the adhesive ability of cancer cells is closely associated with their metastatic activity. In this study, we examine the role of ErbB-2 in regulating the adhesive ability of androgen receptor (AR)-positive human prostate cancer (PCa) cells, the major cell population of PCa. Utilizing different LNCaP and MDA PCa2b cells as model systems, we found that ErbB-2 activity was correlated with PYK2 activity and adhesive ability in those cells. Increased ErbB-2 expression or activity in LNCaP C-33 cells enhanced PYK2 activation and cell adhesion, while the high PYK2 activity and the rapid adhesion of LNCaP C-81 cells were decreased by diminishing ErbB-2 expression or activity. Knockdown studies revealed the predominant role of ErbB-2 in regulating LNCaP C-81 cell adhesion. Coimmunoprecipitation showed that C-81 cells had increased interaction between ErbB-2 and PYK2. Elevated ErbB-2 activity in LNCaP cells correlated with increased ERK/MAPK activity and enhanced adhesive ability, which were abolished by the expression of K457A-PYK2 mutant or the treatment of PD98059, a MEK inhibitor. In summary, our data suggested that ErbB-2, via PYK2-ERK/MAPK, upregulates the adhesive ability of AR-positive human PCa cells.

AB - Aberrant regulation in the adhesive ability of cancer cells is closely associated with their metastatic activity. In this study, we examine the role of ErbB-2 in regulating the adhesive ability of androgen receptor (AR)-positive human prostate cancer (PCa) cells, the major cell population of PCa. Utilizing different LNCaP and MDA PCa2b cells as model systems, we found that ErbB-2 activity was correlated with PYK2 activity and adhesive ability in those cells. Increased ErbB-2 expression or activity in LNCaP C-33 cells enhanced PYK2 activation and cell adhesion, while the high PYK2 activity and the rapid adhesion of LNCaP C-81 cells were decreased by diminishing ErbB-2 expression or activity. Knockdown studies revealed the predominant role of ErbB-2 in regulating LNCaP C-81 cell adhesion. Coimmunoprecipitation showed that C-81 cells had increased interaction between ErbB-2 and PYK2. Elevated ErbB-2 activity in LNCaP cells correlated with increased ERK/MAPK activity and enhanced adhesive ability, which were abolished by the expression of K457A-PYK2 mutant or the treatment of PD98059, a MEK inhibitor. In summary, our data suggested that ErbB-2, via PYK2-ERK/MAPK, upregulates the adhesive ability of AR-positive human PCa cells.

KW - Cell adhesion

KW - ErbB-2

KW - PYK2

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=36749095145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36749095145&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1210570

DO - 10.1038/sj.onc.1210570

M3 - Article

VL - 26

SP - 7552

EP - 7559

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 54

ER -